UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:PELI2-GPHN |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: PELI2-GPHN | FusionPDB ID: 64252 | FusionGDB2.0 ID: 64252 | Hgene | Tgene | Gene symbol | PELI2 | GPHN | Gene ID | 57161 | 10243 |
Gene name | pellino E3 ubiquitin protein ligase family member 2 | gephyrin | |
Synonyms | - | GEPH|GPH|GPHRYN|HKPX1|MOCODC | |
Cytomap | 14q22.3 | 14q23.3-q24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | E3 ubiquitin-protein ligase pellino homolog 2RING-type E3 ubiquitin transferase pellino homolog 2pellino homolog 2pellino-2protein pellino homolog 2 | gephyrin | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q9NQX3 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000267460, | ENST00000544752, ENST00000305960, ENST00000315266, ENST00000459628, ENST00000478722, ENST00000543237, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 9 X 5 X 6=270 | 42 X 51 X 15=32130 |
# samples | 10 | 62 | |
** MAII score | log2(10/270*10)=-1.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(62/32130*10)=-5.69550895508454 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: PELI2 [Title/Abstract] AND GPHN [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PELI2(56645182)-GPHN(67490350), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | PELI2-GPHN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PELI2-GPHN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PELI2-GPHN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PELI2-GPHN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PELI2 | GO:0001934 | positive regulation of protein phosphorylation | 12804775 |
Hgene | PELI2 | GO:0043410 | positive regulation of MAPK cascade | 12804775 |
Tgene | GPHN | GO:0032324 | molybdopterin cofactor biosynthetic process | 26613940 |
Tgene | GPHN | GO:0097112 | gamma-aminobutyric acid receptor clustering | 26613940 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SKCM | TCGA-W3-AA1R-06A | PELI2 | chr14 | 56645182 | - | GPHN | chr14 | 67490350 | + |
ChimerDB4 | SKCM | TCGA-W3-AA1R-06A | PELI2 | chr14 | 56645182 | + | GPHN | chr14 | 67490350 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000267460 | PELI2 | chr14 | 56645182 | + | ENST00000315266 | GPHN | chr14 | 67490350 | + | 2701 | 493 | 286 | 1839 | 517 |
ENST00000267460 | PELI2 | chr14 | 56645182 | + | ENST00000478722 | GPHN | chr14 | 67490350 | + | 2706 | 493 | 286 | 1839 | 517 |
ENST00000267460 | PELI2 | chr14 | 56645182 | + | ENST00000459628 | GPHN | chr14 | 67490350 | + | 917 | 493 | 286 | 726 | 146 |
ENST00000267460 | PELI2 | chr14 | 56645182 | + | ENST00000543237 | GPHN | chr14 | 67490350 | + | 1926 | 493 | 286 | 1839 | 517 |
ENST00000267460 | PELI2 | chr14 | 56645182 | + | ENST00000305960 | GPHN | chr14 | 67490350 | + | 2100 | 493 | 286 | 1839 | 517 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000267460 | ENST00000315266 | PELI2 | chr14 | 56645182 | + | GPHN | chr14 | 67490350 | + | 0.001649991 | 0.99835 |
ENST00000267460 | ENST00000478722 | PELI2 | chr14 | 56645182 | + | GPHN | chr14 | 67490350 | + | 0.001593082 | 0.99840695 |
ENST00000267460 | ENST00000459628 | PELI2 | chr14 | 56645182 | + | GPHN | chr14 | 67490350 | + | 0.022658909 | 0.9773412 |
ENST00000267460 | ENST00000543237 | PELI2 | chr14 | 56645182 | + | GPHN | chr14 | 67490350 | + | 0.004394825 | 0.9956052 |
ENST00000267460 | ENST00000305960 | PELI2 | chr14 | 56645182 | + | GPHN | chr14 | 67490350 | + | 0.003283365 | 0.99671656 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >64252_64252_1_PELI2-GPHN_PELI2_chr14_56645182_ENST00000267460_GPHN_chr14_67490350_ENST00000305960_length(amino acids)=517AA_BP=69 MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKVQSRCSSKENILRASHSAVDI TKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQP TQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVG VTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEK DYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDP -------------------------------------------------------------- >64252_64252_2_PELI2-GPHN_PELI2_chr14_56645182_ENST00000267460_GPHN_chr14_67490350_ENST00000315266_length(amino acids)=517AA_BP=69 MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKVQSRCSSKENILRASHSAVDI TKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQP TQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVG VTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEK DYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDP -------------------------------------------------------------- >64252_64252_3_PELI2-GPHN_PELI2_chr14_56645182_ENST00000267460_GPHN_chr14_67490350_ENST00000459628_length(amino acids)=146AA_BP=69 MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKVQSRCSSKENILRASHSAVDI -------------------------------------------------------------- >64252_64252_4_PELI2-GPHN_PELI2_chr14_56645182_ENST00000267460_GPHN_chr14_67490350_ENST00000478722_length(amino acids)=517AA_BP=69 MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKVQSRCSSKENILRASHSAVDI TKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQP TQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVG VTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEK DYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDP -------------------------------------------------------------- >64252_64252_5_PELI2-GPHN_PELI2_chr14_56645182_ENST00000267460_GPHN_chr14_67490350_ENST00000543237_length(amino acids)=517AA_BP=69 MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPNGDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKVQSRCSSKENILRASHSAVDI TKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQP TQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVG VTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEK DYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDP -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr14:56645182/chr14:67490350) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | GPHN |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Acts as a major instructive molecule at inhibitory synapses, where it also clusters GABA type A receptors (PubMed:25025157, PubMed:26613940). {ECO:0000250|UniProtKB:Q03555, ECO:0000269|PubMed:25025157, ECO:0000269|PubMed:26613940}.; FUNCTION: Has also a catalytic activity and catalyzes two steps in the biosynthesis of the molybdenum cofactor. In the first step, molybdopterin is adenylated. Subsequently, molybdate is inserted into adenylated molybdopterin and AMP is released. {ECO:0000269|PubMed:26613940}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | GPHN | chr14:56645182 | chr14:67490350 | ENST00000315266 | 7 | 22 | 326_736 | 288.0 | 737.0 | Region | Note=MPT adenylyltransferase | |
Tgene | GPHN | chr14:56645182 | chr14:67490350 | ENST00000478722 | 8 | 23 | 326_736 | 321.0 | 770.0 | Region | Note=MPT adenylyltransferase |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PELI2 | chr14:56645182 | chr14:67490350 | ENST00000267460 | + | 2 | 6 | 15_202 | 69.0 | 421.0 | Domain | Note=FHA%3B atypical |
Tgene | GPHN | chr14:56645182 | chr14:67490350 | ENST00000315266 | 7 | 22 | 14_166 | 288.0 | 737.0 | Region | Note=MPT Mo-transferase | |
Tgene | GPHN | chr14:56645182 | chr14:67490350 | ENST00000478722 | 8 | 23 | 14_166 | 321.0 | 770.0 | Region | Note=MPT Mo-transferase |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
PELI2 | |
GPHN | ![]() |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | GPHN | chr14:56645182 | chr14:67490350 | ENST00000315266 | 7 | 22 | 140_316 | 288.0 | 737.0 | GABARAP | |
Tgene | GPHN | chr14:56645182 | chr14:67490350 | ENST00000478722 | 8 | 23 | 140_316 | 321.0 | 770.0 | GABARAP |
Top |
Related Drugs to PELI2-GPHN |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to PELI2-GPHN |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | GPHN | C1854990 | Molybdenum Cofactor Deficiency, Complementation Group C | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | GPHN | C0001956 | Alcohol Use Disorder | 1 | CTD_human |
Tgene | GPHN | C0001973 | Alcoholic Intoxication, Chronic | 1 | CTD_human |
Tgene | GPHN | C0009171 | Cocaine Abuse | 1 | CTD_human |
Tgene | GPHN | C0085762 | Alcohol abuse | 1 | CTD_human |
Tgene | GPHN | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
Tgene | GPHN | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND |
Tgene | GPHN | C0600427 | Cocaine Dependence | 1 | CTD_human |